Catella: Market is turning, easy comps, and a cheap stock
Research Update
2024-08-22
07:25
Analyst Q&A
Closed
Jesper von Koch answered 6 questions.
Redeye states that while the Q2 report was soft, it had some positive highlights - including the sequential SEK3.3bn FX-adjusted AUM growth, and the clear optimism around the upcoming divestment of Kaktus. With the real-estate market appearing to have bottomed out, and with all tough y/y comparisons behind us, Redeye believes the valuation of an estimated EV/EBIT of 4x for 2025e is attractive. Redeye makes minor changes to its estimates and valuation range.
Jesper Von Koch
Martin Wahlström
Contents
Investment thesis
Download article
Q2 came in weaker than we had expected, although the reason continues to be a very dampened market. Particularly Corporate Finance was soft, while Investment Management was solid with positive FX-adjusted AUM growth of SEK3.3bn. However, we believe all 'weak hands' are practically gone in Catella, as even a seemingly weak report did not lead to any substantial decrease in the share price.
Management commented in the earnings call that the interest in Kaktus is high, though investors for this asset type ("core asset") have been very cautious for some time. Catella has had over a dozen pretty active dialogues with large investors. Thanks to its strong financial position, and thus no stress for increased liquidity, Catella will not accept a discount offer on Kaktus. Thus, we remain confident that Catella will generate a substantial profit on Kaktus once it decides to divest it.
Following the Q2 report, we only make small and short-term estimate changes. Our fair value range is changed from SEK27-69 to SEK25-70, with Base Case intact at SEK56. With the expected divestment of Kaktus about to reveal hidden value in Catella, we estimate Catella to be trading at 4x EBIT for 2025e - and even lower for 2026e. While investor sentiment around Catella remains low as the market remains weak, we see an attractive valuation.
SEKm | 2022 | 2023 | 2024e | 2025e | 2026e |
Total Revenue | 2,611.0 | 2,319.0 | 1,988.1 | 2,023.1 | 2,236.6 |
Revenue Growth | 42.4% | -11.2% | -14.3% | 1.8% | 10.6% |
EBITDA | 670.0 | 195.0 | 173.6 | 465.1 | 569.2 |
EBIT | 596.0 | 122.0 | 101.6 | 393.1 | 497.2 |
EBIT Margin | 28.8% | 7.0% | 5.9% | 21.3% | 24.2% |
Net Income | 397.6 | -25.0 | 3.2 | 290.7 | 382.2 |
EV/Sales | 1.7 | 2.4 | 1.1 | 0.9 | 0.7 |
EV/EBIT | 5.9 | 34.0 | 18.3 | 4.0 | 2.7 |
Disclosures and disclaimers
Contents
Investment thesis
Download article